ACE inhibitors can reduce the secretion of aldosterone, which is responsible for potassium excretion. When potassium supplements are taken concurrently, this may lead to an accumulation of potassium in the bloodstream, resulting in hyperkalemia. Elevated potassium levels can disrupt cardiac function and lead to serious complications such as arrhythmias. It is crucial to monitor potassium levels when these medications are used together to avoid dangerous health outcomes.

Hyperkalemia can cause heart palpitations, muscle weakness, and potentially fatal cardiac arrhythmias.

Avoid concurrent use of ACE inhibitors and potassium supplements unless closely monitored by a healthcare professional. Regular blood tests to check potassium levels should be performed, and alternative potassium sources should be explored if necessary.